UREMIC PRURITUS
Clinical trials for UREMIC PRURITUS explained in plain language.
Never miss a new study
Get alerted when new UREMIC PRURITUS trials appear
Sign up with your email to follow new studies for UREMIC PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug offers hope for dialysis Patients' unbearable itching
Symptom relief CompletedThis study tested an experimental drug called MR13A9 in 247 adults on hemodialysis who had severe itching (uremic pruritus). The goal was to see if the drug safely reduces itch intensity compared to a placebo. Participants rated their worst daily itch on a 0-10 scale, and the mai…
Matched conditions: UREMIC PRURITUS
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New drug offers hope for kidney patients suffering from unbearable itching
Symptom relief CompletedThis study tested a drug called difelikefalin in 260 Chinese adults on hemodialysis who had moderate-to-severe itching. Participants received either the drug or a placebo for 12 weeks, with an optional 14-week extension. The main goal was to see if the drug reduced itching intens…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
New hope for dialysis patients suffering from relentless itching
Symptom relief CompletedThis study tested a drug called MR13A9 in 178 adults on hemodialysis who had severe itching not caused by other conditions. Participants received either the drug or a placebo for 4 weeks, followed by an open-label phase to check long-term safety. The main goal was to see if MR13A…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC